Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder
Article in Experimental Hematology & Oncology (August 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?
Article in Bone Marrow Transplantation (November 2023)
Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
Article in International Journal of Molecular Sciences (November 2023)